Advanced Biomed, a Taiwanese developer of microfluidic testing equipment for early cancer screening, lowered the proposed deal size for its upcoming IPO on Monday. In its latest filing, the company also replaced sole bookrunner Univest Securities with Craft...read more
Advanced Biomed, a Taiwanese developer of microfluidic testing equipment for early cancer screening, announced terms for its IPO on Wednesday. The Tainan, Taiwan-based company plans to raise $113 million by offering 25 million shares at a price range of $4 to...read more
There were no IPOs this past week, as the sole scheduled offering (AZTR) delayed to the week ahead. Along with no post-Memorial Day launches, the pipeline was quiet with no new initial filings. The summer IPO market is off to a slow start coming out of May,...read more
Four sizable IPOs raised a combined $4.9 billion in May, the biggest month for proceeds since December 2021. May activity was well below the 10-year average for deal count (19 IPOs) but on par for proceeds ($5.0B), and the month now accounts for two-thirds of...read more
Taiwanese diagnostics developer Advanced Biomed slashes deal size by 92% ahead of $9 million US IPO
Advanced Biomed, a Taiwanese developer of microfluidic testing equipment for early cancer screening, lowered the proposed deal size for its upcoming IPO on Monday. In its latest filing, the company also replaced sole bookrunner Univest Securities with Craft...read more
Taiwanese diagnostics developer Advanced Biomed sets terms for $113 million US IPO
Advanced Biomed, a Taiwanese developer of microfluidic testing equipment for early cancer screening, announced terms for its IPO on Wednesday. The Tainan, Taiwan-based company plans to raise $113 million by offering 25 million shares at a price range of $4 to...read more
US IPO Weekly Recap: May IPO market ends with a quiet week
There were no IPOs this past week, as the sole scheduled offering (AZTR) delayed to the week ahead. Along with no post-Memorial Day launches, the pipeline was quiet with no new initial filings. The summer IPO market is off to a slow start coming out of May,...read more
Renaissance Capital's May IPO Market Update
Four sizable IPOs raised a combined $4.9 billion in May, the biggest month for proceeds since December 2021. May activity was well below the 10-year average for deal count (19 IPOs) but on par for proceeds ($5.0B), and the month now accounts for two-thirds of...read more